Related Experiment Video
Updated: May 23, 2026

Development and Validation of a Methodology for Establishing Obese Rat Models with Typical Fatty Pancreas
Published on: November 11, 2025
Burden of non-cancer comorbidities and mortality in chronic pancreatitis: a retrospective cohort study
Shauntelle Quammie1,2, Adil Rashid1,3, Rahul Munyal4
1NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, UK.
Insights
Patients with chronic pancreatitis (CP) face significantly higher risks of serious comorbidities like heart failure and diabetes. This progressive disease also leads to substantially increased mortality rates compared to the general population.
Area of Science:
- Gastroenterology and Hepatology
- Epidemiology
- Internal Medicine
Background:
- Chronic pancreatitis (CP) is a severe fibro-inflammatory condition.
- CP is linked to increased comorbidities and mortality.
- Understanding the natural history of CP is crucial for patient management.
Purpose of the Study:
- To characterize the natural history of chronic pancreatitis.
- To assess comorbidity prevalence in a CP cohort.
- To evaluate mortality rates in patients with CP.
Main Methods:
- Retrospective cohort study at Nottingham University Hospitals NHS Trust.
- Included patients diagnosed with CP between 2006 and 2014.
- Follow-up until May 2023, comparing comorbidity and mortality with national data.
Main Results:
- Patients with CP showed significantly elevated standardized prevalence ratios (SPRs) for heart failure, diabetes mellitus, ischemic heart disease, atrial fibrillation, and cerebrovascular disease.
- Cumulative incidence at 20 years for diabetes mellitus, chronic liver disease, and chronic kidney disease was 11-12%.
- A high mortality rate was observed, with a standardized mortality ratio (SMR) of 2.3 compared to the general population. Leading causes of death included malignancy, infections, and cardiovascular disease.
Conclusions:
- Chronic pancreatitis is associated with a significantly increased risk of multiple comorbidities.
- Patients with CP experience elevated mortality rates compared to the general population.
- Enhanced surveillance and early intervention strategies are recommended to manage CP-associated conditions.
Objective:
Chronic pancreatitis (CP) is a progressive fibro-inflammatory disease associated with increased comorbidity and mortality. This study aimed to characterise the natural history of CP by assessing comorbidity prevalence and mortality in a CP cohort.
Methods:
A retrospective cohort study was performed at Nottingham University Hospitals NHS Trust, including patients diagnosed with CP between 1 January 2006 and 31 December 2014. Participants were followed up until 31 May 2023. Comorbidity prevalence was compared with national data from England in 2022 to calculate standardised prevalence ratios (SPRs). Similarly, standardised mortality ratios (SMRs) were also evaluated.
Results:
Of the 1003 patients with CP, 678 who resided within the Greater Nottingham area were included in the study cohort. The overall median follow-up was 5.7 years (IQR 1.2-10.6). Compared with the general population, patients with CP had significantly elevated SPRs for heart failure (3.0; 95% CI 2.3 to 3.8), diabetes mellitus (2.4; 95% CI 2.1 to 2.7), ischaemic heart disease (2.4; 95% CI 2.0 to 2.8), atrial fibrillation (1.9; 95% CI 1.5 to 2.3) and cerebrovascular disease (1.4; 95% CI 1.0 to 1.8). The cumulative incidence at 20 years of diabetes mellitus, chronic liver disease and chronic kidney disease was 12%, 11% and 11%, respectively. During follow-up, 495 patients (73%) died, with median survival of 5.7 years (95% CI 4.8 to 6.4). The overall SMR of patients with CP was significantly increased (2.3; 95% CI 2.1 to 2.6; p<0.0001) compared with the general population. Leading causes of death were malignancy (27%), infections (22%) and cardiovascular disease (6.9%).
Conclusion:
CP is associated with increased risk of multiple comorbidities and elevated mortality as compared with the general population. Enhanced surveillance and early intervention strategies may help prevent or delay the onset of these associated conditions.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis II: Pathophysiology
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Pathophysiology
Acute Pancreatitis I: Introduction
